Cargando…
Prognosis and treatment differences between initial and second primary chondrosarcoma
Prognosis and treatment differences between initial and second primary chondrosarcoma (pCS) remain unknown. In the present study, patients with chondrosarcoma diagnosed between January 2004 and December 2015 were identified using the Surveillance Epidemiology and End Results database. Kaplan-Meier c...
Autores principales: | Mao, Weipu, Kong, Minghao, Yu, Haiyang, Wang, Dongyan, Huang, Xin, Yao, Xudong, Fan, Jie, Geng, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539928/ https://www.ncbi.nlm.nih.gov/pubmed/31289490 http://dx.doi.org/10.3892/ol.2019.10329 |
Ejemplares similares
-
Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma
por: Zang, Jie, et al.
Publicado: (2020) -
Risk Factors for Incidence and Prognosis in Chondrosarcoma Patients with Pulmonary Metastasis at Initial Diagnosis
por: Nguyen, Minh Tien, et al.
Publicado: (2019) -
Marital Status and Survival in Patients with Penile Cancer
por: Mao, Weipu, et al.
Publicado: (2019) -
Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression
por: Mao, Weipu, et al.
Publicado: (2019) -
Primary Pancreatic Chondrosarcoma
por: Qiao, Weiguang, et al.
Publicado: (2018)